GASTALDON, CHIARA
 Distribuzione geografica
Continente #
NA - Nord America 2.830
EU - Europa 2.478
AS - Asia 2.166
SA - Sud America 330
Continente sconosciuto - Info sul continente non disponibili 118
AF - Africa 75
OC - Oceania 20
Totale 8.017
Nazione #
US - Stati Uniti d'America 2.722
RU - Federazione Russa 1.061
SG - Singapore 893
CN - Cina 482
IT - Italia 476
GB - Regno Unito 299
BR - Brasile 263
VN - Vietnam 222
HK - Hong Kong 218
DE - Germania 115
FR - Francia 112
IE - Irlanda 109
SE - Svezia 106
BD - Bangladesh 90
FI - Finlandia 76
CA - Canada 71
KR - Corea 62
IN - India 40
ID - Indonesia 34
AR - Argentina 29
ES - Italia 25
MX - Messico 21
NL - Olanda 20
UA - Ucraina 19
TR - Turchia 18
AU - Australia 15
JP - Giappone 15
PL - Polonia 15
BJ - Benin 14
NG - Nigeria 14
TG - Togo 14
IQ - Iraq 13
PK - Pakistan 13
AT - Austria 12
MY - Malesia 12
VE - Venezuela 10
EC - Ecuador 8
PH - Filippine 8
MA - Marocco 7
ZA - Sudafrica 7
ET - Etiopia 5
LB - Libano 5
LT - Lituania 5
NZ - Nuova Zelanda 5
PE - Perù 5
SA - Arabia Saudita 5
SY - Repubblica araba siriana 5
AE - Emirati Arabi Uniti 4
BE - Belgio 4
CL - Cile 4
CO - Colombia 4
GR - Grecia 4
KE - Kenya 4
RO - Romania 4
TW - Taiwan 4
UY - Uruguay 4
UZ - Uzbekistan 4
IR - Iran 3
JM - Giamaica 3
NP - Nepal 3
PT - Portogallo 3
TN - Tunisia 3
BG - Bulgaria 2
BW - Botswana 2
CH - Svizzera 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
GT - Guatemala 2
HN - Honduras 2
HU - Ungheria 2
IL - Israele 2
JO - Giordania 2
LA - Repubblica Popolare Democratica del Laos 2
NI - Nicaragua 2
PY - Paraguay 2
TH - Thailandia 2
AO - Angola 1
AZ - Azerbaigian 1
BB - Barbados 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
CG - Congo 1
DK - Danimarca 1
EE - Estonia 1
HT - Haiti 1
KG - Kirghizistan 1
MD - Moldavia 1
MW - Malawi 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
RS - Serbia 1
SC - Seychelles 1
SN - Senegal 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 7.900
Città #
Singapore 497
Ashburn 427
Moscow 377
San Jose 346
Dallas 260
Southend 219
Hong Kong 205
Chandler 201
Verona 134
Council Bluffs 128
Beijing 101
Dublin 99
New York 97
The Dalles 89
Ho Chi Minh City 67
Jacksonville 56
Los Angeles 52
Woodbridge 51
Lawrence 38
Princeton 38
Santa Clara 38
Munich 37
Hanoi 34
Milan 32
Buffalo 31
Helsinki 31
São Paulo 30
Lappeenranta 29
Rome 29
Jakarta 28
Wilmington 28
Houston 25
Redondo Beach 24
Columbus 23
Jinan 21
London 20
Sindelfingen 19
Dong Ket 18
Washington 18
Frankfurt am Main 15
Guangzhou 15
Orem 15
Toronto 15
Abuja 14
Boardman 14
Cotonou 14
Lomé 14
Nanjing 14
Seattle 14
Shenyang 14
Atlanta 13
Boston 13
Chicago 13
Nuremberg 13
Phoenix 13
Redwood City 13
Turin 13
Kent 12
Montreal 12
Zhengzhou 12
Rio de Janeiro 11
Tokyo 11
Brooklyn 10
Dearborn 10
San Francisco 10
Tianjin 10
Warsaw 10
Amsterdam 9
Changsha 9
Mexico City 9
Curitiba 8
Da Nang 8
Padova 8
Poplar 8
Taizhou 8
Bologna 7
Chennai 7
Denver 7
Haikou 7
Istanbul 7
Manchester 7
Nanchang 7
Stockholm 7
Bari 6
Hangzhou 6
Johannesburg 6
Madrid 6
Nepean 6
Norwalk 6
Palermo 6
Redmond 6
Reggio Emilia 6
Thái Bình 6
Vienna 6
Belo Horizonte 5
Cincinnati 5
Dhaka 5
Fairfield 5
Falkenstein 5
Jiaxing 5
Totale 4.573
Nome #
VORTIOXETINE VERSUS SSRIs FOR THE TREATMENT OF DEPRESSION IN THE ELDERLY: A PRAGMATIC RANDOMIZED CLINICAL TRIAL 289
Come reagiscono al trauma i bambini sfollati? Un’analisi esplorativa degli studi condotti in contesti di guerra. [Displaced versus non-displaced children in war contexts: An explorative analysis of psychological reactions to war experiences] 265
Continuing, reducing, switching, or stopping antipsychotics in individuals with schizophrenia-spectrum disorders who are clinically stable: a systematic review and network meta-analysis 217
Efficacy and acceptability of antidepressants in patients with ischemic heart disease: systematic review and meta-analysis 194
Maintenance treatment with long-acting injectable antipsychotics for people with nonaffective psychoses: a network meta-analysis 192
Drug dose as mediator of treatment effect in antidepressant drug trials: the case of fluoxetine 191
Antipsychotic drug exposure and risk of myocardial infarction 190
Factors associated with first- versus second-generation long-acting antipsychotics prescribed under ordinary clinical practice in Italy 189
Comparative efficacy and acceptability of psychosocial interventions for PTSD, depression, and anxiety in asylum seekers, refugees, and other migrant populations: a systematic review and network meta-analysis of randomised controlled studies 188
Are trials of psychological and psychosocial interventions for schizophrenia and psychosis included in the NICE guidelines pragmatic? A systematic review 172
Benzodiazepines and risk of dementia: true association or reverse causation? 170
Antipsychotic combinations in schizophrenia 165
Effectiveness of Self-Help Plus in preventing mental disorders in refugees and asylum seekers in Western Europe: a multinational randomized controlled trial 162
Antipsychotic use and risk of life-threatening medical events: umbrella review of observational studies 159
Can a digital medicine system improve adherence to antipsychotic treatment? 155
Oral and long-acting antipsychotics for relapse prevention in schizophrenia-spectrum disorders: a network meta-analysis of 92 randomized trials including 22,645 participants 150
Tolerability and efficacy of vortioxetine versus SSRIs in elderly with major depression. Study protocol of the VESPA study: a pragmatic, multicentre, open-label, parallel-group, superiority, randomized trial 148
Efficacy of psychosocial interventions for mental health outcomes in low-income and middle-income countries: an umbrella review 143
Characterising alexithymia in individuals with functional motor disorders: a cross-sectional analysis of the Italian Registry of Functional Motor Disorders 138
CBT treatment delivery formats for panic disorder: a systematic review and network meta-analysis of randomised controlled trials 137
Paroxetine versus other anti-depressive agents for depression 137
Calling for policy actions to increase access to long-acting antipsychotics in low-income and middle-income countries 136
Antipsychotic-Related DRESS Syndrome: Analysis of Individual Case Safety Reports of the WHO Pharmacovigilance Database 135
Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations 132
Withdrawal syndrome following discontinuation of 28 antidepressants: pharmacovigilance analysis of 31,688 reports from the WHO spontaneous reporting database 129
Psychological and social interventions for the promotion of mental health in people living in low- and middle-income countries affected by humanitarian crises 128
New EMA report on paliperidone 3-month injections: taking clinical and policy decisions without an adequate evidence base 128
Esketamine for treatment resistant depression: a trick of smoke and mirrors? 128
Psychotherapies for Generalized Anxiety Disorder in Adults: A Systematic Review and Network Meta-Analysis of Randomized Clinical Trials 126
Clinical trajectories of individuals with severe mental illness continuing and discontinuing long-acting antipsychotics: a one-year mirror-image analysis from the STAR Network Depot study 124
Efficacy and acceptability of long-acting antipsychotics in acutely ill individuals with schizophrenia-spectrum disorders: A systematic review and network meta-analysis 124
Focused psychosocial interventions for children in low-resource humanitarian settings: a systematic review and individual participant data meta-analysis 123
Tolerability of vortioxetine compared to selective serotonin reuptake inhibitors in older adults with major depressive disorder (VESPA): a randomised, assessor-blinded and statistician-blinded, multicentre, superiority trial 122
Comparative efficacy and acceptability of psychotherapies for panic disorder with or without agoraphobia: systematic review and network meta-analysis of randomised controlled trials 122
Long-term effectiveness of Self-Help Plus in refugees and asylum seekers resettled in Western Europe: 12-month outcomes of a randomised controlled trial 122
Disproportionality Analysis From World Health Organization Data on Semaglutide, Liraglutide, and Suicidality 118
Fluoxetine versus other types of pharmacotherapy for depression 114
A systematic review and pooled, patient-level analysis of predictors of mortality in neuroleptic malignant syndrome 112
Efficacy and tolerability of antidepressants in individuals suffering from physical conditions and depressive disorders: network meta-analysis 102
Psychological therapies for the treatment of mental disorders in low- and middle-income countries affected by humanitarian crises 102
Esketamine clinical trials: reply to Maju et al 99
Mediators of focused psychosocial support interventions for children in low-resource humanitarian settings: analysis from an Individual Participant Dataset with 3,143 participants 94
Efficacy and Tolerability of Vortioxetine Versus Selective Serotonin Reuptake Inhibitors for Late-Life Depression: A Post-hoc Analysis of the VESPA Study 86
Pharmacological treatment of hyperactive delirium in people with COVID-19: rethinking conventional approaches 85
Neonatal withdrawal syndrome following in utero exposure to antidepressants: a disproportionality analysis of VigiBase, the WHO spontaneous reporting database 83
Essential medicines for mental disorders: comparison of 121 national lists with WHO recommendations 83
Risk factors of postpartum depression and depressive symptoms: umbrella review of current evidence from systematic reviews and meta-analyses of observational studies 83
Ground-breaking change to the mental health section of the WHO Model List of Essential Medicines: implications for low- and middle-income countries 77
Post-marketing safety concerns with esketamine: a disproportionality analysis of spontaneous reports submitted to the FDA adverse event reporting system 77
Psychological and social interventions for the prevention of mental disorders in people living in low- and middle-income countries affected by humanitarian crises 76
Psychotherapeutic treatments for depression in older adults 75
Updating the WHO Model Lists of Essential Medicines to promote global access to the most cost-effective and safe medicines for mental disorders 75
Peripartum allopregnanolone blood concentrations and depressive symptoms: a systematic review and individual participant data meta-analysis 74
Which psychotherapy is effective in panic disorder? And which delivery formats are supported by the evidence? Study protocol for two systematic reviews and network meta-analyses 74
Efficacy of psychological interventions for PTSD in distinct populations - An evidence map of meta-analyses using the umbrella review methodology 72
Polycystic ovary syndrome and postpartum depression: A systematic review and meta-analysis of observational studies 71
Poor implementation of the EU clinical trial regulation is a major threat for pragmatic trials in European countries 69
Psychological and social interventions for the promotion of mental health in people living in low- and middle-income countries affected by humanitarian crises 67
Have the COVID-19 outbreak and related restrictions affected the right to mental health of people with severe mental health conditions? 67
Reply to the Comments by Doherty et al 61
Postpartum hemorrhage and postpartum depression: A systematic review and meta-analysis of observational studies 60
The WHO Model List of Essential Medicines for Children needs its own identity: the case of psychotropic medicines 58
Esketamine for treatment-resistant depression in adults 56
Comparison of antidepressant deprescribing strategies in individuals with clinically remitted depression: a systematic review and network meta-analysis 47
Mental health service coverage and gaps among adults in Europe: a systematic review 39
History of miscarriage and postpartum depression: a systematic review and meta-analysis of observational studies 37
Efficacy and safety of esketamine for "treatment resistant depression": registered report for a systematic review with an individual patient data meta-analysis of randomized, double-blind, placebo-controlled trials 29
Paternal exposure to antiseizure medications and offspring outcomes: a systematic review and meta-analysis of observational studies 27
Comparative effect of different surgical treatments for ovarian endometrioma on anti-Müllerian hormone levels: a systematic review and network meta-analysis 14
Apixaban, direct oral anticoagulants and psychiatric events: Innocent bystander or true safety signal? 10
Sexual Dysfunction with Antipsychotics: Emerging Clues from a Disproportionality Analysis of the World Health Organization VigiBase 7
Precipitants and clinical features of serotonin syndrome: a systematic review with patient-level analysis of published case reports and series 4
Safe discontinuation of antidepressants in individuals with clinically remitted depressive disorders: study protocol for a randomised controlled trial 3
Totale 8.017
Categoria #
all - tutte 31.320
article - articoli 30.594
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 726
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.640


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022254 0 56 5 19 24 4 9 14 12 3 33 75
2022/2023646 40 60 72 103 57 146 12 46 86 4 17 3
2023/2024555 21 44 37 51 63 117 24 40 9 20 86 43
2024/20251.394 67 77 101 232 75 66 45 85 169 142 102 233
2025/20264.255 284 190 326 637 994 281 422 254 316 261 139 151
2026/2027239 111 128 0 0 0 0 0 0 0 0 0 0
Totale 8.017